Biologics and the Rapid Sterility Testing Market: A Necessary Synergy
The growth of the Rapid Sterility Testing Market is inextricably linked to the explosion of the biologics and biosimilars sector, where complex molecular structures require more frequent and sensitive contamination monitoring. Market size — with a CAGR of 11-13%, the market is heavily influenced by the biotechnology sector, which accounts for nearly thirty-five percent of total demand....
0 Comments 0 Shares 57 Views 0 Reviews